Shuttle Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -633 | -289 | -1 | |
EBITDA | -1,583 | -2,499 | -2,327 | -3,910 |
EBIT | -2,216 | -2,788 | -2,328 | -3,910 |
Net Income | -2,152 | -2,614 | -2,347 | -3,706 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,417 | -973 | -2,626 | -3,355 |
Cash | 1,089 | 334 | 2,094 | 4,817 |
Basic Shares | 5,031 | 2,023 | 2,233 | 1,126 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -290 | -5 | -6 | -5 |
EBITDA | -11,360 | -7,779 | -3,990 | -4,319 |
EBIT | -11,650 | -7,784 | -3,997 | -4,325 |
Net Income | -11,721 | -9,144 | -6,592 | -4,996 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,481 | -7,327 | -5,600 | -2,710 |
Cash | 334 | 1,920 | 2,576 | 8,417 |
Basic Shares | 1,637 | 10,324 | 15,906 | 10,351 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.42 |
2025-12-31 | -$1.29 |
2025-09-30 | -$1.05 |
2025-06-30 | -$3.29 |